Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Amedisys Names Scott Ginn Acting Chief Operating Officer
Amedisys, a leading provider of home health, hospice, personal care and high-acuity care, names Scott […]
HHS Awards ICF Over $45 Million in Digital Modernization Contracts
The U.S. Department of Health and Human Services‘ (HHS) Centers for Medicare & Medicaid Services […]
Health Net Providing Special Assistance to Members Affected by Wildfires and Flash Flooding
In response to Gov. Gavin Newsom‘s declared state of emergencies in Alpine, El Dorado, Inyo, […]
Yes Hearing Announces Expansion of Integrated Home-Based Care Services for Health Plans
Yes Hearing, leading provider of affordable, accessible, and convenient hearing technology and audiology care, has […]
EIB and MedinCell Sign a New €40 Million Loan Agreement to Support Development of Innovative Treatments
European Investment Bank (EIB), backed by the Investment Plan for Europe, and pharmaceutical company MedinCell, […]
Sartorius BIA Separations and Exopharm Sign Joint Research Agreement to Develop Integrated Technology for Large-scale Exosome Production
Sartorius BIA Separations, a leading bio-chromatography company, now part of the international life science group […]
Nanostics Announces New Member of Board of Directors
Nanostics, a precision health diagnostics company, announced today the appointment of Aubrey Rankin to its Board […]
Nyra Medical Announces $20 Million Series A Funding for its Transcatheter Heart Valve Repair Technology
Nyra Medical, a medical device company that is developing a novel transcatheter mitral valve repair […]
Clarify Pharma Acquires Shares in Atai Life Sciences and Compass Pathways
Clarify Pharma, an investment vehicle specialising in biotech and life sciences companies seeking to prove […]
Hemispherian Raises First Tranche of Series A to Fund the Development of its Novel Cancer Therapeutics
Hemispherian AS, a Norwegian preclinical pharmaceutical company focused on small molecule cancer therapeutics targeting the […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more